Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment

Published:2016-12 Issue:12 Volume:3 Page:e569-e578
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

McGowan Ian,Dezzutti Charlene S,Siegel Aaron,Engstrom Jarret,Nikiforov Alexiy,Duffill Kathryn,Shetler Cory,Richardson-Harman Nicola,Abebe Kaleab,Back David,Else Laura,Egan Deidre,Khoo Saye,Egan James E,Stall Ronald,Williams Peter E,Rehman Khaleel K,Adler Amy,Brand Rhonda M,Chen Beatrice,Achilles Sharon,Cranston Ross D

Funder

Bill & Melinda Gates Foundation

ViiV Healthcare

Janssen

Merck

Gilead Sciences

Bristol-Myers Squibb

AbbVie

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference18 articles.

1. Long-acting injectable antiretrovirals for HIV treatment and prevention;Spreen;Curr Opin HIV AIDS,2013

2. Long-acting rilpivirine for HIV prevention;Jackson;Curr Opin HIV AIDS,2015

3. Rilpivirine: drug profile of a second-generation non-nucleoside reverse transcriptase HIV-inhibitor;Ripamonti;Expert Rev Anti Infect Ther,2014

4. Nanoformulations of rilpivirine for topical pericoital and systemic coitus-independent administration efficiently prevent HIV transmission;Kovarova;PLoS Pathog,2015

5. Formulation and pharmacology of long-acting rilpivirine;Williams;Curr Opin HIV AIDS,2015

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment;Signal Transduction and Targeted Therapy;2024-02-21

2. Ex vivo rectal tissue infection with HIV-1 to assess time to protection following oral PrEP with TDF/FTC (a sub-study of the ANRS PREVENIR study);AIDS;2023-11-16

3. Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation;Thrombosis Research;2023-09

4. Preclinical development and pharmacokinetic assessment in macaques of a multipurpose long-acting injectable suspension containing medroxyprogesterone acetate for contraception and rilpivirine for HIV prevention;Journal of Drug Delivery Science and Technology;2023-08

5. Efficacy and safety of long‐acting cabotegravir versus oral tenofovir disoproxil fumarate‐emtricitabine as HIV pre‐exposure prophylaxis: A systematic review and meta‐analysis;Reviews in Medical Virology;2023-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3